Literature DB >> 28102560

Epidemiology of inflammatory bowel diseases from west to east.

Zsuzsanna Vegh1, Zsuzsanna Kurti1, Peter L Lakatos1.   

Abstract

The incidence and prevalence of inflammatory bowel disease (IBD) show considerable variation over time and across geographical regions. The first studies on the epidemiology of IBD were mainly from traditionally high-incidence areas, such as North America, and northern and western Europe. In the last two decades, more and more studies have been published from Eastern European and Asian countries with increasing incidence rates from some regions. According to recent studies, the high incidence and prevalence of IBD in some Western countries is plateauing and in some Eastern countries increasing incidences have been reported. In the era of new multicenter epidemiological studies with common methodology the direct comparison of incidences and prevalences has became possible. In the present review we summarized the currently available literatures on west-east differences in the incidences and prevalences of IBD.
© 2017 Chinese Medical Association Shanghai Branch, Chinese Society of Gastroenterology, Renji Hospital Affiliated to Shanghai Jiaotong University School of Medicine and John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  zzm321990Crohn’s disease; epidemiology; inflammatory bowel disease; ulcerative colitis

Mesh:

Year:  2017        PMID: 28102560     DOI: 10.1111/1751-2980.12449

Source DB:  PubMed          Journal:  J Dig Dis        ISSN: 1751-2972            Impact factor:   2.325


  32 in total

1.  Role of environmental factors in the pathogenesis of Crohn's disease: a critical review.

Authors:  Yueying Chen; Yining Wang; Jun Shen
Journal:  Int J Colorectal Dis       Date:  2019-11-16       Impact factor: 2.571

Review 2.  Certolizumab pegol for maintenance of medically induced remission in Crohn's disease.

Authors:  Shinji Okabayashi; Hajime Yamazaki; Ryohei Yamamoto; Keisuke Anan; Katsuyoshi Matsuoka; Taku Kobayashi; Shinichiro Shinzaki; Yusuke Honzawa; Yuki Kataoka; Yasushi Tsujimoto; Norio Watanabe
Journal:  Cochrane Database Syst Rev       Date:  2022-06-30

3.  Progression of Elderly Onset Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis of Population-Based Cohort Studies.

Authors:  Jacob J Rozich; Parambir S Dulai; Mathurin Fumery; William J Sandborn; Siddharth Singh
Journal:  Clin Gastroenterol Hepatol       Date:  2020-03-03       Impact factor: 11.382

4.  Lizhong decoction ameliorates ulcerative colitis in mice via modulating gut microbiota and its metabolites.

Authors:  Junfeng Zou; Yumeng Shen; Mengjun Chen; Zhimiao Zhang; Suwei Xiao; Chen Liu; Yue Wan; Lei Yang; Shu Jiang; Erxin Shang; Dawei Qian; Jinao Duan
Journal:  Appl Microbiol Biotechnol       Date:  2020-05-17       Impact factor: 4.813

5.  Increased risks of dental caries and periodontal disease in Chinese patients with inflammatory bowel disease.

Authors:  Limin Zhang; Xiang Gao; Jiamin Zhou; Shan Chen; Jinxin Zhang; Yingfan Zhang; Baili Chen; Junying Yang
Journal:  Int Dent J       Date:  2020-01-30       Impact factor: 2.607

6.  Herbal medicine WangShiBaoChiWan improves gastrointestinal health in mice via modulation of intestinal tight junctions and gut microbiota and inhibition of inflammation.

Authors:  Sheng Yin; Chao Sun; Yi Ji; Hamid Abdolmaleky; Jin-Rong Zhou
Journal:  Biomed Pharmacother       Date:  2021-03-21       Impact factor: 7.419

7.  Ischemic or toxic injury: A challenging diagnosis and treatment of drug-induced stenosis of the sigmoid colon.

Authors:  Zong-Ming Zhang; Xiang-Chun Lin; Li Ma; An-Qin Jin; Fang-Cai Lin; Zhuo Liu; Li-Min Liu; Chong Zhang; Na Zhang; Li-Juan Huo; Xue-Liang Jiang; Feng Kang; Hong-Jun Qin; Qiu-Yang Li; Hong-Wei Yu; Hai Deng; Ming-Wen Zhu; Zi-Xu Liu; Bai-Jiang Wan; Hai-Yan Yang; Jia-Hong Liao; Xu Luo; You-Wei Li; Wen-Ping Wei; Meng-Meng Song; Yue Zhao; Xue-Ying Shi; Zhao-Hui Lu
Journal:  World J Gastroenterol       Date:  2017-06-07       Impact factor: 5.742

8.  Long-Term Prognosis of Japanese Patients with Crohn's Disease Treated by Switching Anti-Tumor Necrosis Factor-α Antibodies.

Authors:  Rintaro Moroi; Hisashi Shiga; Katsuya Endo; Katsutoshi Yamamoto; Masatake Kuroha; Yoshitake Kanazawa; Yoichi Kakuta; Yoshitaka Kinouchi; Atsushi Masamune
Journal:  Inflamm Intest Dis       Date:  2019-12-20

9.  Drug Lag for Inflammatory Bowel Disease Treatments in the East and West.

Authors:  Shinji Okabayashi; Taku Kobayashi; Toshifumi Hibi
Journal:  Inflamm Intest Dis       Date:  2018-10-05

10.  Therapeutic preferences and outcomes in newly diagnosed patients with Crohn's diseases in the biological era in Hungary: a nationwide study based on the National Health Insurance Fund database.

Authors:  Zsuzsanna Kurti; Akos Ilias; Lorant Gonczi; Zsuzsanna Vegh; Petra Fadgyas-Freyler; Gyula Korponay; Petra A Golovics; Barbara D Lovasz; Peter L Lakatos
Journal:  BMC Gastroenterol       Date:  2018-01-30       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.